T-cell acute lymphoblastic leukemia
Clinical trials for T-cell acute lymphoblastic leukemia explained in plain language.
Never miss a new study
Get alerted when new T-cell acute lymphoblastic leukemia trials appear
Sign up with your email to follow new studies for T-cell acute lymphoblastic leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Double-Barreled immune attack aims to wipe out T-ALL
Disease control Stopped earlyThis early-phase trial tests a two-part immune therapy for people with T-cell acute lymphoblastic leukemia (T-ALL). First, patients receive specially engineered T cells (CAR-T) that target multiple markers on leukemia cells. Then, they get a booster with cytotoxic T cells and a d…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase 1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Promising combo for tough leukemia stalls: trial ends early
Disease control Stopped earlyThis phase 2 trial tested two drugs, CB-103 and venetoclax, in adolescents and young adults with T-cell acute lymphoblastic leukemia (T-ALL) that had come back or not responded to treatment. The goal was to see if the combination could control the disease. However, the study was …
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC